Ono Pharmaceutical: [Postponed] Corporate Governance Report
Ono Pharmaceutical: Report on Corporate Governance June 27, 2024.
Ono Pharmaceutical: Extraordinary Report
Ono Pharmaceutical: Internal Control Report - 76th Period (2023/04/01 - 2024/03/31)
Ono Pharmaceutical: Confirmation letter
Ono Pharmaceutical: Securities Report - 76th Fiscal Year (April 1, 2023 - March 31, 2024)
Ono Pharmaceutical: Announcements of individual stocks regarding disposal of treasury stock as share-based compensation with continuous transfer restrictions and share-based compensation with performance-based transfer restrictions.
Ono Pharmaceutical: Extraordinary Report
Ono Pharmaceutical: Announcements of individual stocks regarding the results of the public tender offer for shares of Deciphera Pharmaceuticals, Inc. in the USA and acquisition completion (total subsidiaryization).
Ono Pharmaceutical: Notice of the 2024 Convocation Annual General Meeting
Ono Pharmaceutical: 2024 Annual General Meeting of Shareholders Materials (Issued Documents Omitted)
Ono Pharmaceutical: 2024 Annual General Shareholders' Meeting Convocation Notice and Shareholders' Meeting Materials
Ono Pharmaceutical: Independent Officer Notification Form
Ono Pharmaceutical: Extraordinary Report
Ono Pharmaceutical: Notice regarding differences between individual results and previous fiscal year results
Ono Pharmaceutical: Supplemental Financial Results for the Fiscal Year Ending March 31, 2012 (Consolidated IFRS)
Ono Pharmaceutical: Summary of financial results for the fiscal year ending 2024/3 [IFRS] (consolidated)
Ono Pharmaceutical: Notice regarding the conclusion of an agreement to acquire Deciphera Pharmaceuticals in the United States
Ono Pharmaceutical: Stock Purchase Status Report (based on Section 24-6 (1) of the Act)
Ono Pharmaceutical: Notice regarding personnel affairs of directors, auditors, and executive officers
No Data